Home・Список акций・Progyny Inc

Progyny Inc

Закрыт

СекторЗдравоохранение

26.26 2.1

Купить Продать

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

26.14

Макс.

26.29

Ключевые показатели
By Trading Economics
Доход	28M 52M
Продажи	22M 351M
P/E Средняя по отрасли	30.604 57.002
Прибыль на акцию	0.34
Рентабельность продаж	14.917
Сотрудники	835
EBITDA	5.9M 44M

Рекомендации
By TipRanks
Рекомендации	Активная покупка
Прогноз на 12 месяцев	+26.71% upside

Дивиденды
By Acuity
Следующий отчет о доходах	5 нояб. 2026 г.

Рыночная статистика
By TradingEconomics
Рыночная капитализация	-302M 2.1B
Предыдущая цена открытия	24.16
Предыдущая цена закрытия	26.26

Новостные настроения

By Acuity

61%

39%

295 / 340 Рейтинг в Healthcare

Progyny Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

14 авг. 2026 г., 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13 авг. 2026 г., 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12 авг. 2026 г., 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 авг. 2026 г., 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 авг. 2026 г., 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 авг. 2026 г., 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 июл. 2026 г., 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 июл. 2026 г., 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 июл. 2026 г., 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 июл. 2026 г., 17:41 UTC

News

Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 июл. 2026 г., 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 июл. 2026 г., 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 июл. 2026 г., 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Сравнение c конкурентами

Изменение цены

Progyny Inc Прогноз

Целевая цена

By TipRanks

26.71% рост

Прогноз на 12 месяцев

Средняя 33.3 USD 26.71%

Максимум 40 USD

Минимум 27 USD

Основано на мнении 10 аналитиков Wall Street, спрогнозировавших целевые цены для Progyny Inc на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

10 ratings

Покупка

Удержание

Продажа

Основано на мнении 10 аналитиков, присваивавших рейтинги акциям Progyny Inc – Данные за последние 3 месяца.

Настроения

By Acuity

295 / 340Рейтинг в Здравоохранение

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

О компании Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.